巨噬细胞集落刺激因子-1及其受体在牙周炎中的研究进展

doi:10.13701/j.cnki.kqyxyj.2024.03.003

摘要/Abstract

摘要： 牙周炎是一种影响牙齿周围支持组织的慢性炎症性疾病。牙周组织损伤主要由宿主的免疫反应介导,而目前临床治疗牙周炎主要以局部机械清除菌斑和结石为主,免疫疗法在牙周临床中应用很少。因此,对牙周炎免疫治疗的研究就显得极其重要。巨噬细胞参与宿主免疫反应的关键环节,通过识别、吞噬和清除外来病原体和异物在牙周炎的发生、发展过程中发挥重要作用。研究表明,这一过程是通过巨噬细胞集落刺激因子-1(colony stimulation factor-1,CSF-1)/巨噬细胞集落刺激因子-1受体(colony stimulation factor-1 receptor,CSF-lR)信号轴介导的巨噬细胞炎性调控、破骨细胞骨吸收调控进行的。本综述将CSF-1/CSF-1R信号轴在牙周炎中的作用及其作用机制进行总结,以期为后续研究及牙周炎的免疫治疗提供依据。

关键词: 巨噬细胞集落刺激因子-1, 巨噬细胞集落刺激因子-1受体, 巨噬细胞, 破骨细胞, 牙周炎

Abstract: Periodontitis is a chronic inflammatory disease that affects the tissues supporting the teeth. The host immune response is now recognized as the primary cause of tissue damage in periodontitis. Current clinical treatment mainly focuses on removing plaque and calculus mechanically, with limited use of immunotherapy. Nevertheless, it is essential to research immunotherapy for periodontitis. Macrophages play a pivotal role in the host immune response. They recognize, phagocytose, and eliminate foreign pathogens and objects. The colony stimulation factor-1 (CSF-1)/colony stimulation factor-1 receptor (CSF-1R) pathway is involved in the progression of periodontitis by regulating macrophage inflammation and osteoclast bone resorption. Understanding the mechanism of action of CSF-1/CSF-1R in periodontitis is essential for future studies and the development of immunotherapy approaches.

Key words: macrophage colony stimulation factor-1, macrophage colony stimulation factor-1 receptor, macrophage, osteoclast, periodontitis

湛济帆, 田艾. 巨噬细胞集落刺激因子-1及其受体在牙周炎中的研究进展[J]. 口腔医学研究, 2024, 40(3): 199-205.

ZHAN Jifan, TIAN Ai. Advances of Macrophage Colony-stimulating Factor-1 and Its Receptor in Periodontitis[J]. Journal of Oral Science Research, 2024, 40(3): 199-205.

参考文献

[1] Clark D, Halpern B, Miclau T, et al. The contribution of macrophages in old mice to periodontal disease [J]. J Dent Res, 2021, 100(12): 1397-1404.
[2] Wang Q, Nie L, Zhao P, et al. Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging [J]. Int J Oral Sci, 2021, 13(1): 11.
[3] Kassebaum NJ, Smith AGC, Bernabé E, et al. Global, regional, and national prevalence, incidence, and disability-adjusted life years for oral conditions for 195 countries, 1990-2015: a systematic analysis for the global burden of diseases, injuries, and risk factors [J]. J Dent Res, 2017, 96(4): 380-387.
[4] Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets [J]. Nat Rev Immunol, 2011, 11(11): 723-737.
[5] Clark R, Lira-Junior R, Johannsen G, et al. Colony-stimulating factor-1 receptor blockade attenuates inflammation in inflamed gingival tissue explants [J]. J Periodontal Res, 2021, 56(6): 1141-1153.
[6] Chen D, Zhang T, Wang L. The Association of CSF-1 Gene Polymorphism With Chronic Periodontitis in the Han Chinese Population [J]. J Periodontol, 2014, 85(8): e304-e312.
[7] Yang J, Zhu Y, Duan D, et al. Enhanced activity of macrophage M1/M2 phenotypes in periodontitis [J]. Arch Oral Biol, 2018, 96: 234-242.
[8] Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity [J]. Annu Rev Pathol, 2020, 15: 123-147.
[9] Sun Y, Li J, Xie X, et al. Macrophage-osteoclast associations: origin, polarization, and subgroups [J]. Front Immunol, 2021, 12: 778078.
[10] Sun X, Gao J, Meng X, et al. Polarized macrophages in periodontitis: characteristics, function, and molecular signaling [J]. Front Immunol, 2021, 12: 763334.
[11] Hascoët E, Blanchard F, Blin-Wakkach C, et al. New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis [J]. Bone Res, 2023, 11(1): 26.
[12] Hienz SA, Paliwal S, Ivanovski S. Mechanisms of bone resorption in periodontitis [J]. J Immunol Res, 2015, 2015:615486.
[13] 李俊辉,林婷婷,孙瑶.牙周炎中M1型巨噬细胞与破骨细胞形成相关性研究[J].口腔生物医学,2021,12(2):95-99.
[14] 蒋雨璨,李明政,张红梅.巨噬细胞亚型与破骨细胞形成关系的研究进展[J].重庆医科大学学报,2023,48(3):341-345.
[15] Denny WA, Flanagan JU. Small-molecule CSF1R kinase inhibitors; review of patents 2015-present [J]. Expert Opin Ther Pat, 2021, 31(2): 107-117.
[16] Muñoz-Garcia J, Cochonneau D, Télétchéa S, et al. The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis [J]. Theranostics, 2021, 11(4): 1568-1593.
[17] Santamaria-Barria JA, Zeng S, Greer JB, et al. Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells [J]. PLoS One, 2019, 14(5): e0216275.
[18] Achkova D, Maher J. Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer [J]. Biochem Soc Trans, 2016, 44(2): 333-341.
[19] Ensan S, Li A, Besla R, et al. Self-renewing resident arterial macrophages arise from embryonic CX3CR1+ precursors and circulating monocytes immediately after birth [J]. Nat Immunol, 2016, 17(2): 159-168.
[20] Lin H, Lee E, Hestir K, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome [J]. Science, 2008, 320(5877): 807-811.
[21] Freuchet A, Salama A, Remy S, et al. IL-34 and CSF-1, deciphering similarities and differences at steady state and in diseases [J]. J Leukoc Biol, 2021, 110(4): 771-796.
[22] Xu J, Fu L, Bai J, et al. Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways [J]. Stem Cell Res Ther, 2021, 12(1): 268.
[23] Li H, Tang S. Colony stimulating factor-1 and its receptor in gastrointestinal malignant tumors [J]. J Cancer, 2021, 12(23): 7111-7119.
[24] Hagan N, Kane JL, Grover D, et al. CSF1R signaling is a regulator of pathogenesis in progressive MS [J]. Cell Death Dis, 2020, 11(10): 904.
[25] Hume DA, MacDonald KPA. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling [J]. Blood, 2012, 119(8): 1810-1820.
[26] Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions [J]. J Periodontol, 2018, 89 Suppl 1: S173-S182.
[27] Lira-Junior R, Åkerman S, Gustafsson A, et al. Colony stimulating factor-1 in saliva in relation to age, smoking, and oral and systemic diseases [J]. Sci Rep, 2017, 7(1): 7280.
[28] Lira-Junior R, Bissett SM, Preshaw PM, et al. Levels of myeloid-related proteins in saliva for screening and monitoring of periodontal disease [J]. J Clin Periodontol, 2021, 48(11): 1430-1440.
[29] Clark R, Zwicker S, Bureik D, et al. Expression of colony-stimulating factor 1 and interleukin-34 in gingival tissue and gingival fibroblasts from periodontitis patients and controls [J]. J Periodontol, 2020, 91(6): 828-835.
[30] 罗强,顾新华.慢性牙周炎患者牙龈组织中IL-6、IL-34和M-CSFR的表达及临床意义[J].上海口腔医学,2018,27(6):652-656.
[31] 杜莎莎,刘晓燕,耿文华,等.龈沟液Omentin-1、CX3CL1、M-CSFR在慢性牙周炎患者的水平及与病情活动性的相关性研究[J].临床口腔医学杂志,2022,38(10):592-596.
[32] Lira-Junior R, Öztürk VÖ, Emingil G, et al. Salivary and serum markers related to innate immunity in generalized aggressive periodontitis [J]. J Periodontol, 2017, 88(12): 1339-1347.
[33] Rabello D, Soedarsono N, Kamei H, et al. CSF1 gene associated with aggressive periodontitis in the Japanese population [J]. Biochem Biophys Res Commun, 2006, 347(3): 791-796.
[34] Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: a two-way relationship [J]. Diabetologia, 2012, 55(1): 21-31.
[35] Dikilitaş A, Karaaslan F, Evirgenş, et al. Gingival crevicular fluid CSF-1 and IL-34 levels in patients with stage Ⅲ grade C periodontitis and uncontrolled type 2 diabetes mellitus [J]. J Periodontal Implant Sci, 2022, 52(6): 455-465.
[36] Görgülü N G, Doan B. Effect of non-surgical periodontal treatment on salivary and serum biomarkers in Stage Ⅲ Grade B and C periodontitis [J]. J Periodontol, 2022, 93(8): 1191-1205.
[37] Martinez GL, Majster M, Bjurshammar N, et al. Salivary colony stimulating factor-1 and interleukin-34 in periodontal disease [J]. J Periodontol, 2017, 88(8): e140-e149.
[38] Xiang C, Li H, Tang W. Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases [J]. Pharmacol Res,2023, 187:106566.
[39] Stanley ER, Chitu V. CSF-1 receptor signaling in myeloid cells [J]. Cold Spring Harb Perspect Biol, 2014, 6(6): a021857.
[40] 肖天骄,张洁,康佳兵,等. 集落刺激因子1受体抑制剂培西达替尼对脂多糖刺激骨髓来源巨噬细胞衰老的调节作用[J]. 中华口腔医学杂志,2023,58(6):575-583.
[41] Sauter KA, Pridans C, Sehgal A, et al. Pleiotropic effects of extended blockade of CSF1R signaling in adult mice [J]. J Leukoc Biol, 2014, 96(2): 265-274.
[42] Ambrosi TH, Marecic O, McArdle A, et al. Aged skeletal stem cells generate an inflammatory degenerative niche [J]. Nature, 2021, 597(7875): 256-262.
[43] Yadav S, Priya A, Borade DR, et al. Macrophage subsets and their role: Co-relation with colony-stimulating factor-1 receptor and clinical relevance [J]. Immunol Res, 2023, 71(2): 130-152.
[44] Kawabe M, Ohyama H, Kato-Kogoe N, et al. Expression of interleukin-34 and colony stimulating factor-1 in the stimulated periodontal ligament cells with tumor necrosis factor-α[J]. Med Mol Morphol, 2015, 48(3): 169-176.
[45] Zhang D, Jiang Y, Song D, et al. Tyrosine-protein phosphatase non-receptor type 2 inhibits alveolar bone resorption in diabetic periodontitis via dephosphorylating CSF1 receptor [J]. J Cell Mol Med, 2019, 23(10): 6690-6699.
[46] Kimura K, Kitaura H, Fujii T, et al. An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model [J]. Oral Dis, 2014, 20(3): 319-324.
[47] Kitaura H, Kimura K, Ishida M, et al. Effect of cytokines on osteoclast formation and bone resorption during mechanical force loading of the periodontal membrane [J]. ScientificWorldJournal, 2014, 2014:617032.